News search

    E.g., 10/04/2026
    E.g., 10/04/2026
    Research
    29 Jun 2021
    JACC: Spanish scientists provide the first demonstration that triglycerides are a primary risk factor in atherosclerosis

    A study published in JACC shows that excess circulating triglyceride concentrations are associated with subclinical atherosclerosis and vascular inflammation in individuals with low-to-moderate cardiovascular risk according to standard scores
    Dra. Sabio
    About the CNIC
    17 Jun 2021
    Dr Guadalupe Sabio awarded the Banco Sabadell Foundation Prize for Biomedical Research

    The jury acknowledged this CNIC researcher's contribution to understanding why obesity causes cardiometabolic diseases.
    About the CNIC
    8 Jun 2021
    José Antonio Enríquez and Miguel Ángel del Pozo, new members of EMBO

    Dr Enríquez and Dr del Pozo Muñoz join their colleagues Dr Miguel Torres, Dr Pura Muñoz and Dr Francisco Sánchez Madrid,  bringing to five the number of CNIC members in EMBO

    Association between the level of glycosylated hemoglobin and the extent of subclinical atherosclerosis
    Research
    31 May 2021
    JACC: A blood sugar biomarker identifies patients with atherosclerosis and a risk of cardiovascular events

    In an article published in JACC, CNIC scientists report a method for improved ranking of cardiovascular risk in individuals without diabetes
    Sanchez Madrid receives the Santiago Ramón Cajal National Prize in the area of Biology
    About the CNIC
    18 May 2021
    Francisco Sánchez Madrid receives the Santiago Ramón Cajal National Prize in the area of Biology

    The Spanish National Prizes for Research, created in 1982, are the most important awards in Spain in the area of scientific research.
    David Sancho, Carlos del Fresno, Elena Hernández-García, Manuel José Gómez, Francisco Javier Cueto, Salvador Iborra y Paola Brandi.
    Research
    14 May 2021
    JITC: CNIC scientists discover a new strategy to improve cancer immunotherapy

    Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have designed a new strategy to potentiate immunotherapy, the treatment that has revolutionized cancer management
    Jacky Goetz
    About the CNIC
    28 Apr 2021
    "To do science it is essential to be proactive and not wait for your project to progress on its own"

    Dr. Jacky Goetz works on intravital imaging and biomechanical forces during the progression of tumors.
    Mª Ángeles Zuriaga, Mirian Díez, Fátima Sánchez-Cabo, Ana Dopazo, José Javier Fuster, Ana Quintas y Jorge de la Barrera.
    Research
    5 Apr 2021
    JACC: CNIC scientists identify mutations acquired by blood cells that accelerate heart failure progression

    The study, carried out at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and the Hospital Universitario Virgen de Arrixaca in Murcia, establishes clonal hematopoiesis as a new cardiovascular risk factor and an important link between aging and cardiovascular disease
    Valentín Fuster
    About the CNIC
    25 Feb 2021
    The Association of Cardiovascular Imaging of the Spanish Society of Cardiology (SEC) awards its Gold Medal to Dr Valentín Fuster

    Dr Valentín Fuster, Director of the Spanish National Centre for Cardiovascular Research (CNIC) is to receive the Gold Medal of the Association of Cardiovascular Imaging of the Spanish Society of Cardiology (SEC) for his original and innovative scientific activity in cardiovascular imaging to reach new frontiers in cardiovascular health of the heart and brain.
    3D reconstructions of superior (left) and inferior (right) brain regions, showing regions with lower metabolism associated with the presence of atherosclerotic plaques in the carotid arteries. The color code indicates the magnitude of the observation (yellow, strong association; red, lower association). Gray indicates areas showing no association with carotid plaque presence
    Research
    15 Feb 2021
    JACC: Spanish scientists uncover early links between cardiovascular risk and brain metabolism

    Among the modifiable cardiovascular risk factors showing a close association with reduced brain metabolism, the research team found that the most important is hypertension